OBSEVA SA's ticker is OBSV and the CUSIP is H5861P103. A total of 58 filers reported holding OBSEVA SA in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $96,930 | +2.0% | 668,485 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $95,000 | -91.2% | 668,485 | 0.0% | 0.00% | -83.3% |
Q2 2022 | $1,076,000 | +6.6% | 668,485 | 0.0% | 0.01% | +20.0% |
Q1 2022 | $1,009,000 | -12.3% | 668,485 | +15.6% | 0.01% | -16.7% |
Q4 2021 | $1,150,000 | -34.3% | 578,126 | +2.7% | 0.01% | -33.3% |
Q3 2021 | $1,751,000 | +5.7% | 563,126 | +3.0% | 0.01% | 0.0% |
Q2 2021 | $1,657,000 | -14.7% | 546,707 | -8.6% | 0.01% | -25.0% |
Q1 2021 | $1,943,000 | +162.2% | 597,899 | +67.8% | 0.01% | +140.0% |
Q4 2020 | $741,000 | +16.7% | 356,215 | +39.1% | 0.01% | +25.0% |
Q3 2020 | $635,000 | -44.3% | 255,995 | +32.1% | 0.00% | -60.0% |
Q2 2020 | $1,141,000 | +201.9% | 193,803 | +23.5% | 0.01% | +150.0% |
Q1 2020 | $378,000 | +3.3% | 156,944 | +63.6% | 0.00% | +33.3% |
Q4 2019 | $366,000 | -10.1% | 95,923 | +96.1% | 0.00% | 0.0% |
Q3 2019 | $407,000 | -26.4% | 48,911 | 0.0% | 0.00% | -40.0% |
Q2 2019 | $553,000 | -11.7% | 48,911 | 0.0% | 0.01% | -16.7% |
Q1 2019 | $626,000 | +6.8% | 48,911 | 0.0% | 0.01% | 0.0% |
Q4 2018 | $586,000 | -33.6% | 48,911 | 0.0% | 0.01% | -14.3% |
Q3 2018 | $882,000 | – | 48,911 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sofinnova Management VIII, L.L.C. | 3,749,623 | $30,522,000 | 18.61% |
VHCP Management II, LLC | 1,401,343 | $11,407,000 | 3.15% |
Abingworth LLP | 440,000 | $3,480,000 | 2.41% |
New Leaf Venture Partners, L.L.C. | 260,301 | $2,119,000 | 0.98% |
NEA Management Company, LLC | 3,336,563 | $27,160,000 | 0.95% |
DAFNA Capital Management LLC | 86,000 | $700,000 | 0.44% |
Rock Springs Capital Management LP | 840,000 | $6,838,000 | 0.32% |
SPHERA FUNDS MANAGEMENT LTD. | 260,197 | $2,118,000 | 0.30% |
SECTORAL ASSET MANAGEMENT INC | 212,831 | $1,732,000 | 0.22% |
Orbimed Advisors | 2,605,531 | $21,209,000 | 0.20% |